🔗 Share this article

As the US proceeds with unprecedented revisions to its immunization recommendations, a particular individual has surfaced somewhat surprisingly: Dr. Tracy Beth Høeg, a US-based physician and epidemiologist who initially gained attention by casting doubt on Covid shots during the pandemic and has zeroed in on potential deaths following Covid vaccination in her recent position at the US Food and Drug Administration (FDA).

Proposed Changes to Pediatric Immunization Schedule

Public health authorities had intended to reveal major changes to the pediatric vaccination calendar in December, bringing the US with the Danish national calendar, according to reports – a significant shift that would put the US at odds with much of the world with no evidence for improved outcomes. This reveal has been pushed back until the coming year.

In place of the director of the vaccine center, Høeg is set to present at the meeting. She was just designated temporary leader of the FDA’s drug evaluation center, the fifth appointee to head the office this calendar year.

A Shift at the FDA

This interim role may indicate a tighter collaboration between the pharmaceutical and vaccine branches as Høeg and Prasad strengthen their influence at the regulatory agency – and it points to a greater focus upon reevaluating long-standing vaccines at the FDA.

Høeg has often pushed for discontinuing certain pediatric immunization guidelines in the US so as to align more in line with Denmark, a country with universal health coverage and a citizenry about the population of Wisconsin’s.

In her initial statements, she has continued to focus on vaccines – usually the purview of Prasad, chief of the FDA’s vaccine center – instead of pharmaceutical oversight.

Doubts Over Expertise

The appointee has no obvious experience in drug development, approval processes or leadership, which has been typical for past heads of the Center for Biologics Evaluation and Research. She has been employed at the FDA as a senior adviser to the commissioner and the vaccine center since spring.

“It seems she lacks to have the necessary background” for leading the drug-regulation department, stated a neurologist and psychiatrist. “She’s never run a randomized controlled trial. She has no expertise in running a major agency. She lacks background in industry regulation.”

Previous commissioners of CBER would “be deeply familiar with laws and regulations and the underlying principles of medication creation”, commented Janet Woodcock. “Clearly, she lacks the type of experience that prior appointees who led CBER have had.”

CDER has an enormous range of responsibilities at the agency, Woodcock pointed out.

“Everybody just zeroes in on the new drug program, but the generic program clears numerous generic medications. There is also a biosimilars division, over-the-counter program and other areas, and each of these need to be supervised,” Dr. Woodcock said. “The thing you neglect, that’s the thing that I always told people is going to cause problems.”

Furthermore, a substantial administrative component to the role, which supervises in excess of 5,000 staff members. “It is a huge administrative position, if you execute it properly,” Woodcock added.

Official Statement and Contentious Initiatives

In response to questions about Dr. Høeg's credentials and whether this selection represents more teamwork among regulatory chiefs on vaccines, a spokesperson stated that the “questions are based on incorrect premises”.

“This background matches the duties of her position,” the spokesperson said, noting the time Dr. Høeg spent guiding the FDA commissioner on “drug safety and approval science, including predictive safety algorithms and immunization monitoring”.

In her interim role, Høeg inherits the agency head's controversial fast-track approval initiative, a contentious one-day drug-approval program that reportedly worried her preceding directors. “By what process are these medications being selected for this voucher program? Who makes the choices?” Howard asked. “There’s a lot of secrecy occurring at the regulatory body right now.”

Broadly speaking, he remarked, “the Food and Drug Administration seems to be moving towards less stringent oversight of all drugs, except for vaccines.”

Documented Track Record on Vaccines

Regarding immunizations, Dr. Høeg has a more documented, if problematic, history, some experts said. She published a analysis using unverified volunteer-provided data to determine the rate of heart inflammation following COVID-19 immunization. She consulted for the Florida top health official Joseph Ladapo, who was said to have modified findings to imply Covid vaccines are more dangerous than they are.

Among her “desired changes” for the current government featured changing regulations for novel immunizations and halting “unnecessary” vaccines, she remarked after the election on a podcast. At the agency, Dr. Høeg has allegedly suggested barring teenage boys from receiving COVID-19 vaccines.

“She’s an complete true believer who starts off with her beliefs and tailors the evidence to retrofit the evidence in a highly misleading, dishonest way,” Howard stated.

Taking Control and a “Revenge Tour”

Høeg aligned with fellow skeptics, {like|